Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CEFOXITIN

CEFOXITIN SODIUM

Standard Dose
EQ 10GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CEFOXITIN is listed in Drugs@FDA under application 065464 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFOXITIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Sponsor ACS DOBFAR SPA Submission history Latest submission status date: 2016-06-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFOXITIN is listed in Drugs@FDA under application 065464 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFOXITIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Sponsor ACS DOBFAR SPA Submission history Latest submission status date: 2016-06-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.